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Abstract
Hypoxia-inducible factor (HIF) is a nuclear transcription factor that responds to environmental and pathological hypoxia to
induce metabolic adaptation, vascular growth, and cell survival. Here we found that HIF subunits and HIF2a in particular
were normally expressed in the mediobasal hypothalamus of mice. Hypothalamic HIF was up-regulated by glucose to
mediate the feeding control of hypothalamic glucose sensing. Two underlying molecular pathways were identified,
including suppression of PHDs by glucose metabolites to prevent HIF2a degradation and the recruitment of AMPK and
mTOR/S6K to regulate HIF2a protein synthesis. HIF activation was found to directly control the transcription of POMC gene.
Genetic approach was then employed to develop conditional knockout mice with HIF inhibition in POMC neurons, revealing
that HIF loss-of-function in POMC neurons impaired hypothalamic glucose sensing and caused energy imbalance to
promote obesity development. The metabolic effects of HIF in hypothalamic POMC neurons were independent of leptin
signaling or pituitary ACTH pathway. Hypothalamic gene delivery of HIF counteracted overeating and obesity under
conditions of nutritional excess. In conclusion, HIF controls hypothalamic POMC gene to direct the central nutrient sensing
in regulation of energy and body weight balance.
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Introduction
Hypoxia-inducible factor (HIF) is the central nuclear transcription
factor that is induced under environmental (e.g., high altitude) and
pathological (e.g., cancer) hypoxia [1,2]. HIF exists as the
heterodimer of an a subunit and a b subunit; HIFa protein levels
are regulated based on tissue oxygen availability, while HIFb (also
called aryl hydrocarbon receptor nuclear translocator, or ARNT) is
constitutively present [1–4]. Under normoxia, HIFa undergoes
protein hydroxylation, ubiquitination, and degradation, and this
process is mediated by prolyl hydroxylases (PHDs) and ubiqutin E3
ligase pVHL—the product of von Hippel-Lindau (VHL) gene [1–4].
Under hypoxia, PHDs are suppressed, leading to HIFa protein
stabilization and thus the transcriptional action of HIFa/b in
inducing genes that classically regulate metabolicadaptation, vascular
growth, and cell survival [1–4]. Among three HIFa isoforms (HIF1a,
HIF2a,a n dH I F 3 a), HIF1a and HIF2a have been extensively
studied in the literature [1–4]. While both HIF1a and HIF2a
mediate hypoxiaadaptation, HIF2acan controla distinct setoftarget
genes [5,6]. Consistently, the biological consequences of HIF2a
versus HIF1a ablation in mice are different [7–9], suggesting that
HIF2a and HIF1a have divergent physiological functions.
Recent research has elucidated that regulation of HIF1/2a by
hypoxia involves metabolic mediators, such as reactive oxygen
species that can modulate mitochondrial complex III [1–4,10–12].
In addition, HIF is subjected to normoxic regulation, and the
underlying basis has been related to several metabolic signaling
pathways including the PI3K-mTOR cascade [13–15] and SIRT1
[16]. The biochemical regulation of HIF by various metabolic
signals has been implicated to underlie the metabolic program-
ming of tumorigenesis [1–4]. However, it remains unexplored
whether a reverse relationship might exist, i.e., if HIF could be a
primary regulator of metabolic physiology at an organism level
and hence a critical target for controlling metabolic disease, and if
so, what could be the responsible tissue/cell types and the
underlying molecular basis.
The hypothalamus in the central nervous system (CNS) is the
master regulator of energy intake (feeding), energy expenditure,
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regulation involves not only hormonal sensing by molecules such
as leptin and insulin [17–21] but also nutrient sensing by species
such as glucose, amino acid, and fatty acids [22–32]. Compared to
the long-term homeostatic regulation of body weight by
hypothalamic hormonal signaling, hypothalamic glucose sensing
is rapid and predicted to provide an acute and real-time regulation
on metabolic homeostasis. Proopiomelanocortin (POMC)-express-
ing neurons, termed POMC neurons, have been identified to
account for hypothalamic glucose sensing [27,33]. In this report,
we demonstrate that hypothalamic glucose sensing is mediated by
HIF activation and resulting up-regulation of POMC gene and that
HIF loss-of-function in POMC neurons causes glucose desensiti-
zation to promote energy imbalance and obesity development.
Results
HIF Controls POMC Gene Transcription
In order to screen nuclear transcription factors that control
hypothalamic neuropeptide genes, we analyzed the DNA
sequence of POMC promoter and identified a HIF-responsive
element at the proximal promoter region across species from
rodents to humans. POMC is the precursor of hypothalamic
neuropeptide, a-melanocyte-stimulating hormone (a-MSH),
which is an important hypothalamic regulator of feeding and
energy balance, and mutation of POMC gene is sufficient to cause
severe obesity and diabetes in both rodents [34] and humans
[35,36]. Notably, the HIF-binding DNA element (59-GCGTG-39)
is located immediately upstream of the transcriptional initiation
site (TATA box) in the POMC promoter (Figure 1A). In contrast,
the DNA elements for STAT3, the most established nuclear
transcription factor for POMC gene in leptin signaling [37–39], are
located further upstream. Using a luciferase reporter system, we
found that overexpression of HIF1a and HIF2a increased the
activities of transfected POMC promoter by 12 folds and 26 folds,
respectively (Figure 1B). When HIF1a or HIF2a was co-
overexpressed with HIFb, the heterodimeric complex activated
POMC promoter by 362–466-fold (Figure 1B). On the other hand,
deletion of the 5-bp HIF-binding DNA element (59-GCGTG-39)
substantially prevented HIF from activating the mutant POMC
promoter (Figure 1B). All these data suggest that POMC gene
represents a HIF target.
Differential Patterns of HIF1a and HIF2a in the
Hypothalamus
To explore whether there was an anatomic basis to support a
metabolic role of hypothalamic HIF, we then profiled HIF isoform
distribution in the hypothalamus as well as other brain regions.
Western blot analysis of HIF2a showed high protein levels in the
hypothalamus but low levels in many other brain regions,
including cortex, thalamus, olfactory bulb, pons, and cerebellum
(Figure 1C). Unlike HIF2a, HIF1a protein expression was
normally weak throughout the brain (Figure 1C). We then
performed brain immunostaining of HIF2a versus HIF1a. The
specificity of HIF2a and HIF1a antibodies for immunostaining
were both verified through exogenous expression and co-
immunostaining with conjugated epitope tags. In these experi-
ments, hypothalamic GT1-7 cells were transfected with pcDNA3.1
plasmid, which expressed myc-tagged HIF2a or myc-tagged
HIF1a. The induction of HIFa isoforms was detected by the
immunostaining of anti-HIF1a or anti-HIF2a antibody, and the
specificity was confirmed by co-immunostaining with anti-myc
antibody. The results showed that anti-HIF2a antibody (Figure
S1) and anti-HIF1a antibody (Figure S2) provided equal sensitivity
and did not yield cross-reactions. Subsequently, we employed
these two antibodies to map HIF2a versus HIF1a in the brain of
normal C57BL/6 mice. Immunostaining revealed that HIF2a was
abundant in neurons of the mediobasal hypothalamus that
comprised the arcuate nucleus (Figure 1D), but less abundant in
many other brain regions (unpublished data). Compared to
HIF2a, HIF1a was weakly expressed in the hypothalamus
(Figure 1D) and barely detectable in many other brain regions.
Altogether, these data suggest that HIFa, in particular HIF2a,
might be involved in hypothalamic regulation of whole-body
physiology.
HIF Inhibition in POMC Neurons Abrogates Feeding
Regulation of Glucose Sensing
POMC neurons have been known as a major hypothalamic
neuronal type that mediates glucose sensing of the hypothalamus
[27,33]. Hence, we investigated whether HIF inactivation in
POMC neurons could affect hypothalamic glucose sensing in
regulation of feeding. To test this question, we chose to ablate
HIFb gene, since HIFb is mandatory for the DNA binding and
activation of both HIF1 and HIF2 complexes [1–4]. By crossing
POMC-Cre mice [40] with HIFb
lox/lox mice [41], we created a
knockout mouse model with HIFb gene ablated in hypothalamic
POMC neurons, termed POMC/HIFb
lox/lox mice. To evaluate the
efficiency of HIFb ablation in the knockout mice, we further
crossed POMC/HIFb
lox/lox mice with ROSA-flox-STOP-flox-YFP
mice in order to visualize POMC neurons in brain sections. Using
this tool, we revealed that HIFb protein was disrupted in the
majority (,90%) of POMC neurons in POMC/HIFb
lox/lox mice
(Figure 2A&B). The specificity of anti-HIFb antibody was verified
in cultured cells by co-staining of transfected HIFb with the
conjugated tag (Figure S3). The total number and morphology of
hypothalamic POMC neurons were not affected by HIFb gene
ablation (Figure 2C), suggesting that HIF inactivation did not
impair the development of POMC neurons.
POMC/HIFb
lox/lox mice were developmentally indistinguishable
from littermate control HIFb
lox/lox mice. POMC/HIFb
lox/lox mice
Author Summary
The hypothalamus in the brain is a master regulator of
feeding and body weight. The regulation of it is mediated
by the ability of the hypothalamus to sense nutrients
(most importantly glucose) and hormones (such as insulin
and leptin). While hormone has been extensively studied,
we know less about how the hypothalamus can sense
nutrients. It is also unclear whether changes in hypotha-
lamic nutrient sensing can influence the development of
obesity and related disease, and could therefore be
targeted for disease intervention. In this study, we show
that a protein termed hypoxia-inducible factor (HIF) is
normally present in the hypothalamus and able to respond
to glucose. This glucose response leads to the up-
regulation of a hypothalamic neuropeptide, POMC, a
pivotal molecule that controls feeding and body weight
balance. We then developed a mouse model in which HIF
is disrupted in hypothalamic cells that express POMC.
These mice displayed reduced hypothalamic sensitivity to
glucose, resulting in overeating and susceptibility to
obesity. Furthermore, we found that delivery of the HIF
gene into the hypothalamus has strong anti-obesity effects
in mice. We conclude that HIF is a molecular mediator of
hypothalamic glucose sensing and can be potentially
targeted for obesity therapeutics.
HIF in Hypothalamic Glucose Sensing
PLoS Biology | www.plosbiology.org 2 July 2011 | Volume 9 | Issue 7 | e1001112Figure 1. Regulation of HIF on POMC gene and HIF profile in the hypothalamus. (A) Analysis of the proximal region of rat POMC promoter.
Putative HIF binding element, STAT3 binding element, TATA box, and initiation site of mRNA transcription are indicated. (B) HEK 293 cells were
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This knockout mouse model was then employed to test whether
HIFb ablation could compromise nutrient-induced hypothalamic
POMC mRNA expression. Two experimental paradigms were
used: supply of general nutrients through re-feeding post-fasting
and glucose administration through third-ventricle infusion. First,
it was found that re-feeding post-fasting significantly increased
hypothalamic levels of POMC mRNA in control mice, but failed to
do so in POMC/HIFb
lox/lox mice (Figure 2D). HIFb ablation did
not alter mRNA levels of hypothalamic neuropeptides CART,
AGRP, and NPY (Figure 2D) or hindbrain neuropeptide nesfatin-1
(Figure S4A). We also examined a few other nuclear transcription
factors including BSX, FoxO1, and CREB, which can also control
neuropeptide expression. The expression levels of these genes were
unchanged in the hypothalamus of POMC/HIFb
lox/lox mice
compared to controls (Figure S4B). Second, we performed the
experiment using third-ventricle glucose infusion. Similar to re-
feeding, glucose infusion up-regulated hypothalamic POMC
mRNA levels in control mice; however, this up-regulation was
not induced in POMC/HIFb
lox/lox mice (Figure 2E). In sum, the
data suggested that HIF mediates glucose-dependent hypotha-
lamic POMC gene expression.
Subsequently, we investigated whether the HIFb ablation could
compromise the feeding-restricting effect of hypothalamic glucose
sensing. Following a prolonged fasting (24 h), POMC/HIFb
lox/lox
mice and their littermate controls received third-ventricle injection
of glucose via pre-implanted cannula. Indeed, glucose suppressed
fasting-induced feeding in control mice. This anorexic effect
occurred rapidly within 6 h post-injection (Figure 2F) and lasted
throughout 24-h follow-up period (Figure 2G). In contrast,
glucose-induced appetite suppression was substantially abolished
in POMC/HIFb
lox/lox mice (Figure 2F&G). Hence, HIF in POMC
neurons is required for glucose-dependent hypothalamic regula-
tion of feeding behavior.
Absence of Pituitary Changes in POMC/HIFb
lox/lox Mice
POMC cells are present in the hypothalamus as well as the
pituitary; thus, both places were targeted by the Cre-loxp
technique for HIFb ablation in the knockout mice. Following the
above observations in POMC/HIFb
lox/lox mice, we examined
whether the pituitary POMC cells were affected by HIFb ablation
in the knockout mice. Because pituitary POMC is the precursor of
adrenocorticotropic hormone (ACTH), we evaluated the pituitary
ACTH synthesis via ACTH immunostaining. Data revealed that
the numbers of pituitary ACTH-positive cells and ACTH
expression levels were similar between POMC/HIFb
lox/lox mice
and littermate controls (Figure S5A&B). Consistently, pituitary
morphology (Figure S5A), ACTH release (Figure S5C), and
pituitary mass (Figure S5D) in the POMC/HIFb
lox/lox mice were
normal. Also, since the main function of ACTH is to control
adrenal growth and corticosterone release, we analyzed the
histology of adrenal glands from POMC/HIFb
lox/lox mice and
matched controls. Indeed, the adrenal morphology and mass were
comparable between POMC/HIFb
lox/lox mice and the controls
(Figure S5E&F). In line with this profile, blood corticosterone
concentrations in POMC/HIFb
lox/lox mice and controls were also
similar (Figure S5G). Altogether, these data indicated that the
pituitary POMC-ACTH system was not involved in glucose-
related feeding dysregulation of POMC/HIFb
lox/lox mice.
Glucose Suppresses PHDs to Stabilize Hypothalamic
HIF2a
The next question was: How could glucose activate hypotha-
lamic HIF? Since mRNA levels of hypothalamic HIF2a and
HIF1a were not affected by third-ventricle glucose infusion (Figure
S4C), glucose regulation of hypothalamic HIF was not mediated
via HIF mRNA expression. In contrast, third-ventricle glucose
infusion significantly increased HIF2a protein levels in the
hypothalamus (Figure 3A&B, Figure S6A). This effect was not
evident in peripheral tissues of mice that were i.p. injected with
glucose (Figure S6B&C). To understand the molecular basis for
glucose-induced hypothalamic HIF up-regulation, we tested if it
involved PHDs-dependent HIFa hydroxylation and degrada-
tion—which is the classical molecular cascade in regulation of
HIF activity [1,2]. Using the GHO assay, which was established in
the literature [42], we found that third-ventricle glucose delivery
suppressed the hydroxylation activities of PHDs in the hypothal-
amus (Figure 3C). We also examined pVHL, an E3 ubiquitin
ligase that mediates ubiquitination and degradation of hydroxyl-
ated HIFa. Glucose did not change pVHL protein levels in the
hypothalamus (Figure 3A), suggesting that pVHL was not a
primary factor for glucose-induced HIFa up-regulation. Thus,
glucose employs the PHD-pVHL system to induce hypothalamic
HIF up-regulation, although the magnitude of this effect was much
smaller than that of hypoxia (Figure 3B&C). We also analyzed the
binding of HIF2a to p300, since the complex functions in the
nucleus to exert the transcriptional activity. As shown in Figure 3D,
increased hypothalamic HIF2a protein levels were proportionally
associated with the increased binding of HIF2a to p300,
suggesting that up-regulation of hypothalamic HIF2a by glucose
is transcriptionally functional.
HIF Mediates Hypothalamic Glucose Sensing Without
Involving Leptin Signaling
We further asked whether HIF2a might be involved in the
action of leptin, a well-established hormone that employs nuclear
transcription factor STAT3 to mediate hypothalamic regulation of
feeding [17–19]. First, in contrast with the effect of glucose, leptin
administration via the third ventricle did not alter HIF2a protein
levels in the hypothalamus (Figure S7A). Then, we investigated
whether HIF might be required for the signaling and function of
leptin in the hypothalamus. To test this question, we employed a
loss-of-function strategy by analyzing hypothalamic leptin signal-
ing and leptin-dependent feeding regulation in POMC/HIFb
lox/lox
mice. Compared to the control mice, POMC/HIFb
lox/lox mice
showed similar levels of leptin-induced STAT3 phosphorylation in
the hypothalamus including the comprised POMC neurons
(Figure S7C&D). Thus, hypothalamic HIF was responsive to
transfected with firefly luciferase pGL3 controlled by either wildtype (WT) or mutant (Mu) rat POMC promoter, and control renilla luciferase pRL-TK,
together with the indicated combination of pcDNA-HIF1a, pcDNA-HIF2a, pcDNA-HIFb, and empty pcDNA. Mutant POMC promoter was generated by
deleting 59-GCGTG-39 in the WT version of POMC promoter. ** p,0.01, *** p,0.001; n=4 per group. Error bars reflect mean 6 SEM. (C) HIF2a and
HIF1a expression levels in different brain areas of C57BL/6 mice were analyzed using Western blotting. b-actin (b-act) was used as a control. PN, pons;
CB, cerebellum; OF, olfactory bulb; CR, cortex; TH, thalamus; HP, hypothalamus. (D) Brain sections of the mediobasal hypothalamus were prepared
from regular C57BL/6 mice and immunostained with HIF2a antibody (upper panel) or HIF1a antibody (lower panel). HIF2a or HIF1a (green) was co-
immunostained with neuronal marker HuCD (red). Merged images (yellow/orange) revealed neuronal expression of HIF2a or HIF1a protein. 3V, third
ventricle; ARC, arcuate nucleus. Bar=50 mm.
doi:10.1371/journal.pbio.1001112.g001
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PLoS Biology | www.plosbiology.org 4 July 2011 | Volume 9 | Issue 7 | e1001112Figure 2. HIF inactivation in POMC neurons impairs glucose regulation of feeding. (A&B) Hypothalamic sections from POMC/HIFb
lox/lox
mice and control HIFb
lox/lox mice were stained with HIFb (red). YFP (green) was introduced to these mice (via crossing these mice with ROSA-flox-
STOP-flox-YFP mice) to visualize POMC neurons. DAPI staining shows nuclei of all cells in the sections. Bar=25 mm. Graphs: percentage of HIFb-
positive POMC neurons. *** p,0.001; n=3–4 per group. Error bars reflect mean 6 SEM. (C) Counting analysis for the total numbers of POMC neurons
across anterior, medial, and posterior arcuate nucleus of POMC/HIFb
lox/lox mice versus control HIFb
lox/lox mice. n=4 per group. Error bars reflect mean
6 SEM. (D) 24-h fasted young POMC/HIFb
lox/lox mice (P/HIFb
l/l) and control littermate HIFb
lox/lox mice (HIFb
l/l) received 6-h re-feeding (R) versus
continued 6-h fasting (F). Hypothalami were subsequently harvested for the measurement of neuropeptide mRNA levels. (E) 24-h fasted young
HIF in Hypothalamic Glucose Sensing
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hypothalamic glucose sensing did not involve the induction of
leptin signaling (Figure S7B). To evaluate the physiological
relevance of this finding, experiments were performed to compare
leptin-dependent feeding regulation in POMC/HIFb
lox/lox mice
versus control mice. Data showed that food intake in POMC/
HIFb
lox/lox mice and the matched controls were suppressed by
leptin in a similar manner (Figure S7E). Altogether, while STAT3
is a critical nuclear transcription factor in leptin signaling, HIF
represents a nuclear transcription factor that crucially mediates the
glucose-sensing process of the hypothalamus.
Glucose Up-Regulates Hypothalamic HIF2a via Fumarate
and Succinate
It has been recently demonstrated that glucose metabolites
fumarate and succinate can inhibit PHDs to activate HIF in
cancer cells to promote tumorigenesis [4]. Hinted by this
information, we questioned if fumarate and succinate could
mediate glucose-dependent HIF activation in the hypothalamus.
To examine this idea, we first confirmed the prediction that
glucose delivery via the third ventricle increased the production of
fumarate and succinate in the hypothalamus (Figure 4A&B). Then,
after having established the appropriate dose- and time-course
conditions (Figure S8A–D), we revealed that HIF2a protein levels
in the hypothalamus of normal C57LB/6 mice were significantly
increased by a third-ventricle delivery of either fumarate or
succinate (Figure 4C, Figure S8E&F). Furthermore, fumarate and
succinate were both found to suppress the PHD hydroxylation
activities in the hypothalamus (Figure 4D). These data indicated
that these two glucose metabolites activated hypothalamic HIF via
the PHD-pVHL pathway.
Subsequently, we examined whether manipulation of hypotha-
lamic fumarate or succinate could affect feeding in mice. As
established in the literature [43,44], succinate and fumarate can be
accumulated by using inhibitors of either a succinate dehydroge-
nase, thenoyltrifluoroacetone (TTFA), or a fumarate hydratase
inhibitor, trans-aconitate, or 3-nitropropionic acid (3-NPA). We
found that individual delivery of these chemicals via third-ventricle
injection inhibited fasting-induced food intake of mice (Figure
S9A) without evident toxic/aversive effects (Figure S9B). Then, we
tested if succinate or furmarate administration into the third
ventricle of mice could affect their feeding activities. Indeed, we
found that a third-ventricle injection of either fumarate or
succinate suppressed food intake in the control mice. In contrast,
such effects were significantly reduced in POMC/HIFb
lox/lox mice
(Figure 4E&F). Hence, fumarate and succinate are two glucose
metabolites that can mediate glucose up-regulation of hypotha-
lamic HIF.
AMPK Down-Regulation by Glucose Mediates
Hypothalamic HIF Activation
Recent research has revealed AMPK as an ‘‘energy gauge’’ in
hypothalamic regulation of energy balance [30–32]. In this
context, we asked if AMPK could be involved in hypothalamic
HIF signaling and action. Using AMPKa phosphorylation to
reflect AMPK activity, we found that an intra-third ventricle
injection of glucose inhibited hypothalamic AMPK (Figure 5A&B).
Then, we performed intra-third-ventricle injection of glucose in
the presence or absence of AICAR, an established AMPK
activator. Data revealed that AICAR markedly reduced the effect
of glucose in hypothalamic HIF up-regulation (Figure 5A&B). This
result indicated AMPK might work as an inhibitory regulator for
glucose-dependent HIF activation in the hypothalamus.
Also, it has recently been reported that activation of hypothalamic
AMPK by AICAR can promote food intake in mice [45,46]. After
having confirmed this effect in our experiment, we tested whether
hypothalamic HIF could prevent the feeding-promoting effects of
AICAR. To do this, we delivered HIF2a/HIFb complex into the
neurons in the mediobasal hypothalamus, since POMC neurons are
predominantly localized in this region. Through a neuron-specific
lentiviral vector in whichdual synapsin promoters were used to direct
co-expression of two genes (Figure S10A), HIF2a and HIFb were co-
delivered into the mediobasal hypothalamus of standard C57BL/6
mice (Figure S10B&C). Mice receiving lentiviral delivery of GFP
were used as controls (Figure S10B). As shown in Figure 5C&D, a
third-ventricle administration of AICAR promoted food intake in
control mice as expected; however, this effect of AICAR was
eliminated by the exogenous expression of HIF2a/HIFb complex.
Thus, AMPK suppression by glucose is mechanistically involved in
glucose sensing of the hypothalamic HIF pathway.
Up-regulation of mTOR/S6K by Glucose Mediates
Hypothalamic HIF Activation
We also examined the potential relevance of mTOR and its
downstream component S6K, since mTOR/S6K can promote
HIF1/2a protein synthesis in various experimental models [1,2],
and also AMPK can inhibit mTOR/S6K [47,48]. We observed
that glucose-dependent hypothalamic HIF2a up-regulation was
associated with increased S6K activities (Figure 6A&B). Converse-
ly, glucose induction of hypothalamic HIF2a was significantly
reversed by third-ventricle injection of mTOR inhibitor, rapamy-
cin (Figure 6A&B). Supported by recent research that has shown
that hypothalamic mTOR [24,49] and S6K [50] restrict feeding
and weight gain, we further evaluated if mTOR/S6K might
participate in the action of hypothalamic HIF in regulation of
feeding. Using the site-specific gene delivery approach described
above, we delivered lentiviruses expressing constitutively active
Rheb (
CARheb) to directly activate mTOR in the mediobasal
hypothalamus of POMC/HIFb
lox/lox mice versus littermate controls
(Figure 6C–F). As revealed in Figure 6F, while
CARheb decreased
food intake in control mice, this effect was reduced in POMC/
HIFb
lox/lox mice. In summary, glucose sensing of HIF in POMC
neurons critically involves mTOR/S6K signaling.
HIF Inhibition in POMC Neurons Causes Overfeeding and
Energy Imbalance
Following the studies addressing glucose sensing of hypothalamic
HIF (Figures 2–6), we examined whether HIF inhibition in POMC
neurons could be sufficient to affect the steady-state levels of feeding
and energy homeostasis. First, energy (food) intake and expenditure
were profiled in POMC/HIFb
lox/lox mice and littermate controls
under normal chow feeding. Compared to the controls, POMC/
HIFb
lox/lox mice were found hyperphagic (Figure 7A) with impaired
energy expenditure (Figure 7B&C), but resulting in only a mild
POMC/HIFb
lox/lox mice (P/HIFb
l/l) and control littermate HIFb
lox/lox mice (HIFb
l/l) received injection of glucose (Glu) versus vehicle (Veh) via cannula pre-
implanted into the third ventricle. Hypothalami were then harvested for the measurement of POMC mRNA. (F&G) Young, male POMC/HIFb
lox/lox mice
(P/HIFb
lox/lox mice) versus littermate control HIFb
lox/lox mice were fasted 24 h and received third-ventricle injection of glucose or vehicle. Food was
placed in cages, and mice were subsequently monitored for food intake for 6 h (F) and 24 h (G). (D–G) * p,0.05, ** p,0.01, NS, non-significant; n=6–
14 per group. Error bars reflect mean 6 SEM.
doi:10.1371/journal.pbio.1001112.g002
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body weight effect, DEXA scanning revealed that fat mass of POMC/
HIFb
lox/lox mice increased evidently (Figure 7D). Morphological
examination ofvarious fat tissues further confirmed that the size of fat
cells isolated from the knockout mice increased (Figure 7E). These
physiological changes in the knockout mice were associated with
impaired thermogenic response of brown fat tissue to re-feeding
(Figure S11). We also tested if the obesogenic effect of hypothalamic
HIF loss-of-function could result from leptin resistance. To do this,
ob/ob mice received mediobasal hypothalamic injection of lentiviruses
expressing dominant-negative HIFa, which has been established to
inhibit both HIF1a and HIF2a [51,52]. The results revealed that the
obesity-promoting effect of HIF loss-of-function remained in ob/ob
mice (Figure S12), indicating that leptin signaling was not involved in
the metabolic action of hypothalamic HIF. Taken together, HIF loss-
of-functioninPOMCneuronscausespositiveenergybalanceinfavor
of obesity development.
HIF Inhibition in POMC Neurons Exacerbates Dietary
Obesity
To further elucidate the significance of hypothalamic HIF inhi-
bition in obesity development, we maintained POMC/HIFb
lox/lox
mice and the littermate controls under high-fat diet (HFD) feeding
since weaning. Despite caloric abundance (58.5 Kcal% fat) in the
HFD, POMC/HIFb
lox/lox mice continued to display an overeating
behavior (Figure 7F). Thus, the knockout mice were insensitive to
the enriched levels of calories from HFD, again supporting the
notion that HIF inactivation in POMC neurons reduced the
nutrient-sensing function of the hypothalamus. We monitored the
longitudinal course of body weight gain and obesity development
in HFD-fed POMC/HIFb
lox/lox mice versus controls. Compared to
HFD-fed control mice, HFD-fed POMC/HIFb
lox/lox mice gained
body weight more rapidly and displayed obesity in an exacerbated
manner (Figure 7G). Thus, when challenged with obesity-prone
conditions (such as HFD feeding), the susceptibility of disease
development is highly increased by HIF dysfunction in hypotha-
lamic POMC neurons, supporting the importance of HIF in the
pathogenesis of obesity-diabetes syndrome.
Treatment of Obesity by Targeting HIF in the
Hypothalamus
Finally, we performed animal studies to evaluate whether
hypothalamic HIF could be targeted to generate strong therapeu-
tic effects against obesity. Although HIF2a is the major subunit in
the hypothalamus (Figure 1C&D), we designed experiments to
evaluate the potential use of both HIF2a and HIF1a. Using the
lentiviral co-expression system shown in Figure S10A&B, we
delivered HIF2a/HIFb versus HIF1a/HIFb into the mediobasal
hypothalamus of normal C57BL/6 mice. Matched mice with gene
delivery of GFP were used as the controls. Following viral
injection, all mice were maintained on an HFD and longitudinally
followed up for feeding and weight gain. As shown in Figure 8A&B,
the control mice gained body weight, rapidly leading to overt
obesity over a 3-mo period. In contrast, delivery of either HIF2a/
HIFb or HIF1a/HIFb markedly reduced obesity development
(Figure 8A&B). The anti-obesity effect of HIF gain-of-function was
clearly attributed to feeding restriction (Figure 8C&D) presumably
resulting from POMC gene expression up-regulation (Figure
S10D). In conclusion, although hypothalamic HIF2a/HIFb is
more physiologically relevant to metabolic regulation, both HIF2a
and HIF1a hold significant therapeutic potentials and can be
targeted, individually or in combination, in order to counteract
obesity and related metabolic diseases.
Figure 3. Regulation of hypothalamic HIF by glucose. (A) 24-h
fasted adult C57BL/6 mice received 5-h third-ventricle infusion of
glucose (Glu) or vehicle (Veh), and hypothalami were analyzed by
Western blots. Bar graphs: Western blot results were normalized by b-
actin (b-act) and analyzed statistically. *** p,0.001, n=6 per group. (B)
24-h fasted regular C57BL/6 mice received third-ventricle infusion of
glucose (Glu) versus vehicle (Veh). Positive controls included 6-h
hypoxia (Hpx) treatment. Hypothalami were then harvested for Western
blot analysis of HIF2a protein levels. b-actin (b-act) was used as an
internal control. Bar graphs: HIF2a protein levels were normalized by b-
actin and analyzed statistically. ** p,0.01; n=5–6 per group. Error bars
reflect mean 6 SEM. (C) 24-h fasted adult C57BL/6 mice received 5-h
third-ventricle infusion of glucose (Glu) versus vehicle (Veh). Positive
controls included matched mice that received 6-h hypoxia (Hpx)
treatment. Hypothalami were dissected and lysed for the measurement
of PHD activity using the GHO assay. PHD activity is expressed by the
ratio of hydroxylated GHO substrate (
OHSub) to intact GHO substrate
(Sub). PHD2 and b-actin levels in the lysates were also measured using
Western blots. Bar graphs: quantitative analysis of PHD activities. *
p,0.05, ** p,0.01; n=6 per group. Error bars reflect mean 6 SEM. (D)
24-h fasted regular C57BL/6 mice received third-ventricle infusion of
glucose (Glu) versus vehicle (Veh). Hypothalami were isolated, lysed,
and analyzed for co-immunoprecipitation of endogenous HIF2a and
p300 using HIF2a immunoprecipitation (IP) followed by HIF2a and p300
immunoblotting (IB) detection. Protein lysates were examined by
Western blots for b-actin (b-act). Bar graphs: immunoprecipitated HIF2a
and p300 were normalized by b-actin and analyzed statistically.
* p,0.05, ** p,0.01; n=5–6 per group. Error bars reflect mean 6
SEM. (A–D) All mice were male C57BL/6 under normal chow feeding.
doi:10.1371/journal.pbio.1001112.g003
HIF in Hypothalamic Glucose Sensing
PLoS Biology | www.plosbiology.org 7 July 2011 | Volume 9 | Issue 7 | e1001112Figure 4. Glucose metabolites mediate glucose regulation of hypothalamic HIF. (A&B) 24-h fasted C57BL/6 mice received third-ventricle
infusion of glucose versus vehicle. Hypothalami were harvested and measured for tissue contents of fumarate (A) and succinate (B). * p,0.05; n=5–6
per group. Error bars reflect mean 6 SEM. (C&D) 24-h fasted C57BL/6 mice received third-ventricle infusion of diethyl fumarate (Fum) or diethyl
succinate (Suc) or control vehicle (Veh). Hypothalami were harvested for Western blot analysis of HIF2a protein (C) and GHO assay for PHD activities
(D). Bar graphs: HIF2a protein levels (C) and PHD activities (D) were quantitated and analyzed statistically. ** p,0.01; n=5–6 per group. Error bars
reflect mean 6 SEM. (E&F) 24-h fasted POMC/HIFb
lox/lox mice (P/HIFb
l/l) and control littermates HIFb
lox/lox mice (HIFb
l/l) received third-ventricle injection
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This study demonstrates that HIF is present in the hypothal-
amus and sensitively up-regulated by the local availability of
glucose and its metabolites. Glucose up-regulation of hypotha-
lamic HIF is mediated by PHD/pVHL-dependent HIFa degra-
dation and AMPK/mTOR-dependent HIFa synthesis. POMC
neurons in the hypothalamus are critical for the metabolic role of
hypothalamic HIF through its direct transcriptional regulation on
POMC gene. HIF loss-of-function in POMC neurons can cause
overeating and weight gain to promote obesity development, while
HIF gain-of-function can provide strong therapeutic benefits
against obesity (and related diseases) (Figure 9). Taken together, all
these unexpected findings reveal an unappreciated role for
neuronal HIF in the brain regulation of energy, body weight,
and metabolic balance.
Energy homeostasis is fundamental for living, and this
physiological process relies on the complex property of the life’
regulatory system in coordinately sensing and transducing the
metabolic dynamics in the body. The hypothalamus is known as
the ‘‘headquarters’’ for the regulation of energy balance
[17,18,53,54]. This work discovered that the HIF complex plays
a critical role in linking hypothalamic glucose sensing to glucose-
dependent hypothalamic control of feeding and energy balance.
Known as a nuclear transcription factor that mediates hypoxia
adaptation, the physiological and disease significance of HIF has
traditionally been explored for the pathological roles in diseases,
particularly cancers [1–3]. Recently, research in cancer biology
has begun to appreciate that tumorigenesis involves the connection
between HIF and metabolism at cellular levels [55,56]. Here, we
have demonstrated an important but unappreciated role of HIF in
the hypothalamus at an organism level from the perspective of
feeding and body weight regulation as well as metabolic disease,
especially obesity and related health problems. Indicated by our
findings, further lines of research can be expected to explore
possible roles of neuronal HIF in other physiological functions and
disease relevance of the hypothalamus.
For almost a decade, the hypothalamus has been established as
a lipostatic feeding regulator through hormonal action of leptin,
which involves activation of POMC by STAT3 [37–39,57].
Figure 5. Effect of AMPK in glucose-mediated activation of hypothalamic HIF. (A&B) Western blot analyses of AMPK signaling were
performed for the hypothalami harvested from C57BL/6 mice that received a 5-h intra-third ventricle infusion of glucose (Glu) versus vehicle (Veh) in
the presence or absence of a prior third-ventricle injection of AICAR. b-act, b-actin. Bar graphs: Western blots were quantitated and analyzed
statistically. (C&D) C57BL/6 mice received mediobasal hypothalamic injection of neuron-specific lentiviruses expressing HIF2a/HIFb (HIF2a/b) or GFP,
and simultaneously received cannula implantation into the third ventricles. After 2-wk post-surgical recovery, mice received 6-h fasting and then were
injected with AICAR or vehicle (Veh) via the cannula. Mice subsequently had free access to food and were measured for food intake during 1-h (C) and
3-h (D) periods. (B–D) * p,0.05, ** p,0.01, *** p,0.001; n=6 per group. Error bars reflect mean 6 SEM.
doi:10.1371/journal.pbio.1001112.g005
of diethyl fumarate (Fum) (E), diethyl succinate (Suc) (F), or vehicle (Veh) (E&F), and subsequently monitored for food intake for 6 h. * p,0.05;
** p,0.01; n=7–10 per group. Error bars reflect mean 6 SEM. (A–F) All mice were adult males and normal chow-fed.
doi:10.1371/journal.pbio.1001112.g004
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PLoS Biology | www.plosbiology.org 9 July 2011 | Volume 9 | Issue 7 | e1001112Figure 6. Regulation of mTOR pathway on hypothalamic HIF. (A&B) 24-h fasted adult C57BL/6 mice received 5-h third-ventricle infusion of
glucose (Glu) versus vehicle (Veh) in the presence or absence a prior third-ventricle injection of rapamycin (Rap). Hypothalami were harvested and
analyzed by Western blotting for phosphorylated S6K (pS6K) and HIF2a. b-act, b-actin. Bar graphs: Western blots were quantitated and analyzed
statistically. * p,0.05, ** p,0.01; n=4 per group. Error bars reflect mean 6 SEM. AU, arbitrary unit. (C–F) POMC/HIFb
lox/lox mice (P/HIFb
l/l) and control
littermate HIFb
lox/lox mice (HIFb
l/l) received MBH injection of lentiviruses expressing the constitutive-active form of Rheb tagged with Flag
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PLoS Biology | www.plosbiology.org 10 July 2011 | Volume 9 | Issue 7 | e1001112Recently, the role of the hypothalamus in nutrient sensing has
become a major interest in the research field, leading to the
elucidation of hypothalamic glucose sensing involving AMPK [30–
32] and KATP channels [27] and hypothalamic amino acid-
sensing process involving mTOR [24]. In this study, we discovered
that HIF in the hypothalamus acts as a nutrient sensor. In
alignment with the fast turnover rate of HIF proteins (half life:
5,10 min) [1,2], the HIF pathway in hypothalamic POMC
neurons likely directs the real-time homeostasis of feeding and
energy homeostasis. This regulation complements STAT3-depen-
dent POMC gene expression in leptin signaling and its long-term
regulation on feeding and body weight [39,57,58]. Additional
research seems needed to address if HIF pathway can work in
other neuronal types in addition to POMC neurons in mediating
hypothalamic control of metabolic physiology. Overall, this work
has specifically focused on the glucose-sensing process of the
(Lenti-
CARheb/Flag) or matched GFP-expressing control lentiviruses (Lenti-GFP). Site-specific gene delivery was verified by immunostaining (C) and
Western blots of Rheb/mTOR signaling proteins (D) as well as the quantitation analysis of Western blots (E). Food intake of these mice was monitored
on a daily basis for 2 wk (F). * p,0.05, ** p,0.01; n=5–6 per group. Error bars reflect mean 6 SEM. AU, arbitrary unit. (A–F) All mice were adult males
and normal chow-fed.
doi:10.1371/journal.pbio.1001112.g006
Figure7.InactivationofHIFinPOMCneuronscausesenergyandmetabolicimbalance.(A–C) Chow-fed POMC/HIFb
lox/lox mice (P/HIFb
lox/lox)a n d
littermate control HIFb
lox/lox were analyzed for food intake (A) and O2 consumption (B&C). * p,0.05; n=10 per group (A) and n=4 per group (B&C).
Statistics in (A) delineate the difference between two mice groups at the indicated time points. Error bars reflect mean 6 SEM. (D) DEXA scanning of fat
mass (versus lean mass) in chow-fed POMC/HIFb
lox/lox (P/HIFb
lox/lox) mice and littermate control HIFb
lox/lox (HIFb
l/l)m i c e .*p,0.05; n=6 per group. (E) H&E
staining of epididymal fat from normal chow-fed POMC/HIFb
lox/lox (P/HIFb
lox/lox) mice and littermate control HIFb
lox/lox mice. Bar=100 mm. (F&G) HFD-fed
POMC/HIFb
lox/lox mice (POMC/HIFb
lox/lox) and littermate control HIFb
lox/lox mice were monitored for food intake (F) and weight gain (G). * p,0.05; n=9–13
per group. Statistics display the difference between two mice groups at the indicated time points. Error bars reflect mean 6 SEM. (A–G) Data were male
mice but similarly observed in females.
doi:10.1371/journal.pbio.1001112.g007
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study whether HIF pathway can function in the central sensing
process of other nutrient species (such as amino acids and fatty
acids) and their metabolites.
The hypothalamus has been well appreciated as the master
regulator of body weight and metabolic balance and a pathogenic
culprit for obesity and related disease [17–21]. Recent research
attentions have been extensively directed to hypothalamic hormonal
dysregulations and most notably the development of leptin resistance
and insulin resistance [59–63]. However, it remains poorly
understood how hypothalamic nutrient sensing is mediated. More
importantly, it is still unclear if a molecular pathway in central
nutrient sensing could be targeted to effectively counteract obesity
a n dr e l a t e dd i s e a s e .I nt h i sw o r k ,w ef o u n dt h a te n h a n c i n g
hypothalamic glucose sensing through HIF induction per se is
effective in treating obesity. Our findings are supported by a recent
work showing an anti-obesity effect of HIF activation through the
ablation of an HIF inhibitor FIH throughout the brain [64]. We
recognize that there is a great deal of research efforts aimed to
develop HIF inhibitors for cancer therapeutics, but concerns were
recently raised about some serious problems that can arise from HIF
inhibition in certain tissues and cells [65]. Here our research further
points out that HIF inhibition in the hypothalamus can result in
adverse metabolic outcomes and needs to be avoided in drug designs.
On the other hand, selective activation of neuronal HIF especially in
the hypothalamus could be developed to provide a new therapeutic
avenue against obesity and related metabolic disease. Neuron-specific
HIF activation might not have critical concerns in terms of
oncogenesis since neurons are non-replicable, but the potential
application of this strategy in treating metabolic disease will certainly
require future technology development and safety assessment.
Materials and Methods
Animal Models and Metabolic Phenotyping
HIFb
lox/lox mice [41] and POMC-Cre mice [40] described
previously were maintained on the C57BL/6 strain background.
ROSA-flox-STOP-flox-YFP mice were from Jackson Laboratory. All
the mice were housed in standard conditions. High-fat diet
(58.5 Kcal% fat) was purchased from Research Diets, Inc. Mice
were measured for body weight and food intake on either a daily
or regular basis. DEXA scanning was performed using the DEXA
scanner at the Primate Center at the University of Wisconsin. The
physiological markers of energy expenditure, including O2
consumption and CO2 production, were measured using the
metabolic chambers (Columbus Instrument, Inc.) at the DRTC
core at Albert Einstein College of Medicine. The Institutional
Animal Care and Use Committee approved all the procedures.
Third Ventricle Cannulation, Chemical Infusion, and
Injection
As previously described [59], an ultra-precise small animal
stereotactic apparatus (10-mm resolution, David Kopf Instrument)
was used to implant a guide cannula into the third ventricle of
anesthetized mice at the midline coordinates of 1.8 mm posterior
to the bregma and 5.0 mm below the bregma. The mice were
allowed 2 wk for surgical recovery. Angiotensin II-stimulated
drink response was used to verify success of implantation.
Individual mice were restrained in a mouse restrainer, and infused
with an indicated reagent over the indicated time period a 26-
gauge guide cannula and a 33-gauge injector (Plastics One)
connected to a Hamilton Syringe and an infusion pump (Harvard
Apparatus). Glucose, diethyl fumarate ester, and diethyl succinate
Figure 8. Anti-obesity effect of delivering HIF to the hypothalamus. Age- and weight-matched C57BL/6 mice received mediobasal
hypothalamic injection of neuron-specific lentiviruses expressing HIF2a/HIFb (Lenti-HIF2a/HIFb) (A&C), HIF1a/HIFb (Lenti-HIF1a/HIFb) (B&D), or GFP
(Lenti-Control) (A–D). Mice were subsequently maintained under HFD feeding and monitored for body weight gain (A&B) and HFD intake (C&D). The
control mice were shared by both groups but repeatedly presented in separate figures. Statistics show the difference between two mice groups at
the time points indicated by lines. * p,0.05; n=5–8 per group. Error bars reflect mean 6 SEM.
doi:10.1371/journal.pbio.1001112.g008
HIF in Hypothalamic Glucose Sensing
PLoS Biology | www.plosbiology.org 12 July 2011 | Volume 9 | Issue 7 | e1001112ester were from Sigma. Nutrient/chemical infusion experiments
for terminal molecular assays: glucose (10 nmol/min), diethyl
fumarate (50 nmol/min), and diethyl succinate (50 nmol/min)
were infused over 2 to 8 h. Rapamycin and AICAR injections
were, respectively, 50 ng and 15 mg per injection (at hour 0, 2, and
4 during the 5-h experimental period). The injection experiments
for acute physiological tests used a single injection of glucose
(40 nmol), diethyl fumarate ester (0.2 mmol), diethyl succinate ester
(0.2 mmol), and AICAR (3 mg) in a 2 ml vehicle over 5 min.
Chemicals, Plasmids, and Recombinant Lentiviral Vectors
Glucose and rapamycin were from Sigma, and AICAR from
Toronto Research Chemicals. Artificial cerebrospinal fluid (aCSF)
was used as the vehicle for glucose, leucine, insulin, leptin, and
AICAR. Full-length cDNAs for HIF1a, HIF2a, and HIFb,
provided by D. Peet, were sub-cloned into pcDNA3.1 plasmids
(Invitrogen). DNA for POMC promoter (provided by S. Melmed)
was sub-cloned to pGL3 (Promega). Mutant POMC promoter was
generated by deleting 59-GCGTG-39 in the WT version of POMC
promoter. For the lentivirus that co-expresses HIF subunits, we
introduced the encoding cDNA of HIF1a or HIF2a and HIFb
into the lentiviral vector Lox-Syn-Syn (provided by G. Francisco)
in which two synapsin promoters control neuron-specific co-
expression of two inserts. For lentivirus that directs expression of
single gene, we sub-cloned PCR fragment of dominant-negative
HIF2a (HIF2a amino acids 1–485) [51,52] or constitutively active
Rheb (
CARheb) (provided by J. Avruch) into pLenti6/V5 vector
(Invitrogen).
Viruses, Injection, and Verification
The lentiviruses were produced from HEK293T cells through
co-transfecting the target plasmid with two package plasmids
(VSVg and delta 8.9) using Ca3(PO4)2. Lentiviruses were purified
by ultracentrifugation. Ultracentrifuge purified lentivirus in 0.2 ml
aCSF was injected over 10 min through a 26-gauge guide cannula
and a 33-gauge injector (Plastics One) connected to a Hamilton
Syringe and an infusion pump (WPI Instruments). As previously
described [59], bilateral injections to the mediobasal hypothala-
mus were directed using an ultra-precise stereotax with 10-mm
resolution (Kopf Instruments) to the coordinates of 1.5 mm
posterior to the bregma, 5.8 mm below the bregma, and
0.3 mm lateral to midline.
Western Blots and Histology
As we previously described [59], the hypothalamus was
dissected along the anterior border of the optic chiasm, posterior
border of the mammillary body, upper border of the anterior
commissure, and lateral border halfway from the lateral sulcus in
the ventral side of brain. Animal tissues were homogenized, the
proteins dissolved in a lysis buffer, and Western blot was
performed as previously described [59,66,67]. Proteins dissolved
in a lysis buffer were separated by SDS/PAGE and identified by
immunoblotting or immunoprecipitation followed by immuno-
blotting. Primary antibodies included anti-HIF1a, anti-HIF2a,
and anti-PHD2 (Novus Biologicals); anti-p300 (Santa Cruz); and
anti-VHL, anti-pS6K, anti-S6K, anti-pAMPKa, anti-AMPKa,
and anti-b-actin (Cell Signaling). Secondary antibodies included
HRP-conjugated anti-rabbit and anti-mouse antibodies (Pierce).
Western blots were quantified using NIH Image J software.
Tissue histology: Various tissues were removed from mice and
fixed in Bouin’ solution (Sigma). Parafilm sections were prepared,
stained with H&E, and examined under a bright field
microscope.
GHO Assay and Biochemical Measurements
PHD activity was determined using the GHO assay as
established in the literature [42]. Briefly, a wheat germ in vitro
transcription-translation (IVTT) system (Promega) was used to
produce unhydroxylated HA-tagged GHO protein (substrate of
PHDs). Hydroxylation of GHO protein was performed by
incubation with hypothalamic protein lysates (dissolved in HEB
buffer) at 37uC for 15 min in the presence of 1 mM ascorbate and
100 mM FeSO4 (Sigma). The reaction was terminated by adding
SDS loading buffer, and hydroxylated versus unhydroxylated
GHO protein was separated by PAGE gels and detected by
Western blot analysis of HA tag. Fumarate and succinate were
measured using Fumarate Assay Kit (BioVison) and Succinic Acid
Kit (Megazyme).
Cell Culture and Luciferase Assay
HEK 293 and HEK 293T (ATCC) were maintained in DMEM
with 5%–10% FBS, glutamate, antibiotics, and in 5%–10% CO2
at 37uC. Transfection of cultured cells with luciferase plasmids and
expression plasmids was performed through Lipofectamine 2000
Figure 9. Glucose sensing of HIF in hypothalamic control
energy and metabolic balance. Proposed model of hypothalamic
HIF in neural control of energy balance. Glucose activates hypothalamic
HIF through metabolite-induced suppression of HIF protein degrada-
tion and AMPK/mTOR-related promotion of HIF protein synthesis.
Activation of HIF up-regulates POMC gene, linking hypothalamic
glucose sensing to the hypothalamic control of feeding, energy
expenditure, body weight, and metabolic homeostasis. In conclusion,
HIF in the hypothalamus represents a molecular target of protecting
hypothalamic nutrient sensing in order to improve whole-body
metabolic regulation of the hypothalamus and prevent against obesity
and related diseases.
doi:10.1371/journal.pbio.1001112.g009
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internally control firefly activity. Empty plasmids pGL3 and
pcDNA3.1 were used as negative controls.
Quantitative RT-PCR
We extracted total RNA from the homogenized hypothalamus
using TRIzol (Invitrogen). Complementary DNA was synthesized
using the M-MLV RT system (Promega). PCR amplification was
quantified using SYBRHGreen PCR Master Mix (Applied
Biosystems). Results were normalized against the expression of
house-keeping genes including TATA box-binding protein (TBP)
and GAPDH.
Heart Perfusion, Immunostaining, and Imaging
Mice under anesthesia were trans-heart perfused with 4% PFA,
and the brains were removed, post-fixed in 4% PFA for 4 h, and
infiltrated in 20%–30% sucrose. Brain sections (20-mm thickness)
were made using a cryostat at 220uC. For cell culture, cells were
cultured in coverslips and fixed using 4% PFA. Fixed tissues or
cells were blocked with serum of appropriate species, penetrated
with 0.2% Triton-X 100, treated with primary antibodies
including rabbit anti-HIF1a, anti-HIF2a (Novus Biologicals),
anti-HIFb (Cell Signaling), mouse anti-HuCD (Molecular Probes),
and subsequently followed by a fluorescent reaction with Alexa
Fluor 488 or 555 secondary antibody (Invitrogen). Naı ¨ve IgGs of
the appropriate species were used as negative controls. DAPI
staining was used to reveal all the cells in the slides. A con-focal
microscope was used to image fluorescence.
Behavioral Tests and Treatments
Fasting induced food intake. The individually housed mice
were measured for food intake. One hour before the designated
‘‘night time,’’ a reagent (nutrient species) dissolved in 1–2 mlo f
vehicle or the empty vehicle (control) was injected to fasted mice
through third ventricle cannula that were pre-implanted 1 to 2 wk
prior to the commencing of experiments. Food was then returned
to the mice immediately before the designated ‘‘night time.’’ Food
intake for each mouse was measured for the following periods as
indicated. Hypoxia treatment: Animal was maintained in a hypoxia
chamber supplied with 8% O2 and 92% nitrogen for 6 h as
established in the literature [68].
Statistical analyses. ANOVA and Tukey’ post hoc analyses
were used for comparisons, which involved more than two groups.
Kolmogorov-Smimov (KS) test was applied to each dataset to
determine the appropriate statistical test (e.g., parametric or
nonparametric) for analysis of each set of data. Two-tailed
Student’ t tests were used for comparisons, which involved only
two groups. Data from electrophysiology recording were
compared using paired t test. Software for performing statistics
included Excel, GraphPad Instat 3, and Prism. Data were
presented as mean 6 SEM. p,0.05 was considered significant.
Supporting Information
Figure S1 Verification of HIF2a antibody specificity. Hypotha-
lamic GT1-7 cells cultured in slides were transfected with
pcDNA3.1 vector expressing myc-tagged HIF2a (left panel),
myc-tagged HIF1a (right panel), or empty vector (middle panel).
Cells were fixed and co-immunostained using HIF2a antibody
(red) and myc antibody (green). Nuclei of all cells in the slides were
revealed by DAPI staining (blue). Merge of colors indicates co-
immunostaining by the two antibodies. Bar=50 mm.
(TIF)
Figure S2 Verification of HIF1a antibody specificity. Hypotha-
lamic GT1-7 cells cultured in slides were transfected with pcDNA3.1
vector expressing myc-tagged HIF1a (left panel), myc-tagged HIF2a
(right panel), or empty vector (middle panel). Cells were fixed and co-
immunostained using HIF1a antibody (red) and myc antibody
(green). Nuclei of all cells were revealed by DAPI staining (blue).
Merge of colors indicates co-immunostaining by the two antibodies.
Bar=50 mm.
(TIF)
Figure S3 Verification of HIFb antibody specificity. Hypotha-
lamic GT1-7 cells cultured in slides were transfected with
pcDNA3.1 vector expressing HA-tagged HIFb. Cells were fixed
and co-immunostained using anti-HIFb antibody (red) and anti-
HA antibody (green). Nuclei of all cells were revealed by DAPI
staining (blue). Merge of colors indicates co-immunostaining by
the two antibodies. Bar=50 mm.
(TIF)
Figure S4 Gene expression profiles in POMC/HIFb
lox/lox mice.
(A&B) Following 24-h fasting, POMC/HIFb
lox/lox mice (P/HIFb
l/l)
and control HIFb
lox/lox mice (HIFb
l/l) received 6-h re-feeding (R)
versus continued 6-h fasting (F). Hindbrain (A) and hypothalami
(B) were subsequently harvested for the measurement of mRNA
levels of indicated genes. n=6–8 per group. Error bars reflect
mean 6 SEM. (C) Following 24-h fasting, C57BL/6 mice received
injection of glucose versus vehicle via cannula pre-implanted into
the third ventricle. Hypothalami were harvested for the measure-
ment of HIF1a versus HIF2a mRNA levels. n=5–8 per group.
Error bars reflect mean 6 SEM.
(TIF)
Figure S5 Profile of pituitary POMC-ATCH system in POMC/
HIFb
lox/lox mice. (A–D) POMC/HIFb
lox/lox (P/HIFb
lox/lox) mice
and littermate control HIFb
lox/lox mice were analyzed for pituitary
ACTH immunostaining (A&B), blood ACTH concentration (C),
and pituitary weight (D). (A) Pituitary sections contained anterior
pituitary (AP) and posterior pituitary (PP) that had no ACTH cells
and was outlined by broken lines. (B) ACTH cells were counted
based on pituitary cross-sections that were cut at midline point,
and data presented represent the analysis of at least 3 mice per
group. Error bars reflect mean 6 SEM. (E&F) POMC/HIFb
lox/lox
(P/HIFb
lox/lox) mice and littermate controls (HIFb
lox/lox mice) were
analyzed for adrenal gland morphology via H&E staining (E) and
adrenal gland weight (F). (G) POMC/HIFb
lox/lox (P/HIFb
lox/lox)
mice and control littermates (HIFb
lox/lox mice) mice were
psychosocially stressed or intact. Serum samples were collected
from these mice and measured for corticosterone concentrations.
n=5–6 per group. Error bars reflect mean 6 SEM.
(TIF)
Figure S6 Profiles of hypothalamic versus peripheral glucose-
HIF connection. (A) Following 24-h fasting, C57BL/6 mice
received third-ventricle injection of glucose at the indicated doses.
HIF2a protein levels in the hypothalamus were examined by
Western blots. b-actin was used as an internal control. (B&C)
Following 24-h fasting, C57BL/6 mice received intraperitoneal
injection of glucose (Glu) (2 g/kg body weight) or vehicle. HIF2a
protein levels in the liver (B) and lung (C) tissues were examined by
Western blots. b-actin was used as an internal control.
(TIF)
Figure S7 Relationship between leptin signaling and hypotha-
lamic HIF pathway. (A) C57BL/6 mice received third ventricle
injection of leptin or vehicle (Veh). The hypothalami were
harvested for Western blot analysis HIF2a protein levels. b-actin
was used as an internal control. (B) Regular C57BL/6 mice
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vehicle (Veh). For comparison, a subset of mice received third
ventricle injection of leptin (Lep). Hypothalami were harvested for
Western blot analysis of STAT3 phosphorylation (pSTAT3) and
STAT3 protein levels. Western blots of b-actin were performed as
an internal control. (C&D) POMC/HIFb
lox/lox mice (P/HIFb
lox/lox)
and control littermate HIFb
lox/lox mice received third ventricle
injection of leptin or control vehicle. Brain sections of mediobasal
hypothalamus were prepared and immunostained for phosphor-
ylated STAT3 (pSTAT3) (green) and a-MSH (red). DAPI nuclear
staining (blue) revealed all cells in the sections. ARC, arcuate
nucleus. Bar=50 mm. (D) POMC neurons (a-MSH-immunore-
active) positive for pSTAT3 in multiple sections were counted and
analyzed statistically. Data represent the observations from at least
3 mice per group. Error bars reflect mean 6 SEM. (E) Young,
male POMC/HIFb
lox/lox mice (P/HIFb
lox/lox mice) versus littermate
control HIFb
lox/lox mice were fasted 24 h and received third-
ventricle injection of leptin or vehicle. Food was placed in cages,
and mice were subsequently monitored for food intake. * p,0.05;
n=6–8 per group. Error bars reflect mean 6 SEM.
(TIF)
Figure S8 Dose-course and time-course actions of fumarate or
succinate. Following 24-h fasting, C57BL/6 mice received third-
ventricle infusion of diethyl fumarate or diethyl succinate at the
dose of 0, 0.6, 3.0, or 15 mmol/h for 5 h (A&C) or at the dose of
3.0 mmol/h for 0, 2, 5, or 8 h (B&D). Hypothalami were harvested
and measured for the tissue contents of fumarate and succinate (A–
D) and HIF2a protein (E&F). Bar graphs: * p,0.05; n=6–8 per
group. Error bars reflect mean 6 SEM.
(TIF)
Figure S9 Food intake and taste aversion effects of pharmacologic
chemicals. (A) Following 24-h fasting, C57BL/6 mice received third-
ventricle injection of trans-aconitate (ACON), thenoyltrifluoroace-
tone (TTFA), 3-nitropropionic acid (3NPA), or vehicle (Veh). Food
was provided to mice and food intake of mice was recorded.
* p,0.05; n=7–10 per group. Error bars reflect mean 6 SEM. (B)
C57BL/6 mice were habituated to experimental protocol for several
days and then presented to 0.2% saccharine for 60 min after
removing the drinking water for 23 h. After habitation, mice were
ICV injected with an indicated drug and the vehicle (Veh) via pre-
implanted third ventricle cannula, and subsequently had access to
0.2% saccharine for 60 min (Test 1). Intraperitoneal (IP) injection of
LiCl and saline was used as a positive and negative control,
respectively. After 4 d, mice were presented with 0.2% saccharine,
and saccharine intake of mice during 60 min was measured (Test 2).
Data represent 60-min saccharine intake in Test 2. ** p,0.01, ns,
non-significant; n=6–7 per group. Error bars reflect mean 6 SEM.
ACON, trans-aconitate; TTFA, thenoyltrifluoroacetone; 3NPA,
3-nitropropionic acid.
(TIF)
Figure S10 Lentivirus-directed hypothalamic HIF delivery up-
regulates POMC gene. (A) Schematic map of lentivirus that co-
expressed myc-conjugated HIFa (either HIF2a or HIF1a) and
HA-conjugated HIFb (Lenti-HIF2a/HIFb) under the control of
neuron-specific synapsin (Syn) promoter. Matched GFP-express-
ing lentiviral vector (Lenti-GFP) was used as a control. (B&C)
C57BL/6 mice received intra-mediobasal hypothalamic injection
of Lenti-HIFa/HIFb or control Lenti-GFP. (B) Site-specific gene
delivery was verified by GFP (green) and HA staining (red). DAPI
nuclear staining (blue) reveals all cells in the sections. Right
panels: GFP (green) and neuronal marker HuCD staining (red)
are merged to indicate neuron-specific gene delivery (yellow). (C)
Site-specific gene delivery was verified by Western blot analysis of
myc and HA expression. Data shown in (B&C) were obtained
from the mice injected with Lenti-HIF2a/HIFb versus Lenti-
GFP, but also represented similar patterns in mice injected with
Lenti-HIF2a/HIFb versus Lenti-GFP. ARC, arcuate nucleus;
3V, third ventricle; b-act, b-actin. Bar=50 mm. (D) Chow-fed
regular C57BL/6 mice that received bilateral MBH injections of
Lenti-HIF2a/HIFb or Lenti-GFP. At 2 wk post-injection,
hypothalami were harvested for the measurement of POMC
mRNA levels.
* p,0.05; n=5 per group. Error bars reflect mean 6 SEM.
(TIF)
Figure S11 Thermogenic activities in POMC/HIFb
lox/lox mice.
Following 24-h fasting, POMC/HIFb
lox/lox mice (P/HIFb
l/l) and
control HIFb
lox/lox mice (HIFb
l/l) received 6-h re-feeding versus
continued 6-h fasting. Hypothalami were collected and analyzed
for mRNA levels of indicated genes. * p,0.05, ** p,0.01, ns, non-
significant; n=5–8 per group. Error bars reflect mean 6 SEM.
(TIF)
Figure S12 Effects of HIF on the metabolic phenotype in ob/ob
mice. (A&B) Body weight-matched ob/ob mice (8 wk old) received
intra-mediobasal hypothalamic injection of neuron-specific lenti-
viruses expressing dominant-negative HIF1/2a (
DNHIF1/2a)o r
control GFP. Mice were monitored for body weight (BW) gain
during 2-wk follow-up (A) and daily food intake during this follow-
up period (B). * p,0.05; n=5–6 per group. Error bars reflect
mean 6 SEM.
(TIF)
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